Key insights
- A social media post discusses PBYI, a company developing Alisertib, a cancer drug currently in phase trials. Positive trial outcomes could lead to significant revenue. This is a bullish signal for PBYI, but the success of drug trials is uncertain and the post is not from a verified source. The overall impact on the US equity market is limited to the specific company.
Howdy folks. I’ve just came across this company, ticker PBYI. I have read that they are dumping profits at an alarming rate into this new Alisertib cancer drug that is going through phase trials right now. My question being, has anyone heard of this? specifically within the medical field? What are your opinions and thoughts on the drug. If the drug trials go well, it could be a multi billion dollar pipeline for the company. Just curious as I’m familiar with investing however I’m much less familiar with cancer and its costs and medications/effectiveness.